查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1635780

馬獸醫治療市場：全球產業分析、市場規模、佔有率、成長、趨勢和預測（2025-2032 年）

Equine Veterinary Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 142 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發佈了對全球馬獸醫治療市場的全面分析。該報告對市場推動因素、趨勢、機會和課題等關鍵市場動態進行了全面的評估，並對市場結構提供了詳細的見解。該報告提供了獨家數據和統計數據，概述了全球馬獸藥市場的預期成長軌跡（2025-2032 年）。

主要的洞察

  • 馬獸藥市場規模（2025 年）：14 億美元
  • 市場規模預測（價值基礎，2032 年）：23 億美元
  • 全球市場成長率（CAGR，2025-2032）：6.7%

馬獸醫治療市場：分析範圍

馬獸醫治療對於預防、診斷和治療影響馬匹的健康狀況至關重要。該市場包括針對馬匹特定需求而量身訂製的藥品、疫苗和營養補充品。這些藥物被獸醫、馬科診所和馬主廣泛用於治療感染、關節疾病、寄生蟲感染和其他健康問題。市場成長的動力來自於人們對馬匹健康認識的不斷提高、對馬術運動的投資不斷增加以及獸醫學的進步。市場也受益於擴大採用疫苗和營養補充劑等預防性護理解決方案來確保馬匹的健康。

市場成長動力：

全球馬獸醫治療市場受到幾個關鍵因素的推動，包括馬絞痛、蹄葉炎和馬流感等馬疾病的盛行率不斷上升。越來越多的人參與馬術運動和娛樂活動，促使人們對馬匹健康的興趣增加，獸醫護理支出也增加。此外，生物技術的進步促進了標靶療法的發展，提高了治療效果並最大限度地減少了副作用。馬主對預防性醫療保健重要性的認識不斷提高也是推動疫苗和營養補充劑需求的關鍵因素。馬科動物診所網路的不斷擴大和先進診斷工具的日益普及進一步推動了市場的成長。

市場限制：

儘管馬獸醫治療市場成長前景看好，但它面臨著治療成本上升、獸醫專家短缺和監管障礙等課題。馬藥和疫苗的費用對小型馬主來說太昂貴，特別是在可支配收入有限的新興國家。此外，有關獸藥審批和使用的嚴格規定給製造商帶來了合規負擔，從而減緩了產品的推出。某些療法相關的副作用風險以及馬匹醫療治療缺乏足夠的保險覆蓋進一步抑制了市場的成長。

市場機會：

在技術創新、城市化進程加快和馬匹護理標準不斷發展的推動下，馬獸醫治療市場提供了巨大的成長機會。馬匹穿戴式監測設備等數位健康技術的整合將增強疾病的早期發現並促進預防性護理。此外，新型生物製劑和基因療法的開發為治療以前無法治癒的疾病開闢了新的途徑。馬術旅遊日益普及以及人們對伴侶動物健康的日益關注為市場參與者創造了更多機會。預計研發方面的策略性投資以及製藥公司和馬術組織之間的合作將推動市場擴張。

本報告解答的關鍵問題

  • 推動全球馬獸醫治療市場成長的關鍵因素有哪些？
  • 哪些產品領域需求量最大？
  • 獸醫學的進步如何影響馬匹治療市場的競爭格局？
  • 馬獸醫治療市場的主要參與者是誰？他們採用了什麼策略來維持市場競爭力？
  • 全球馬獸醫治療市場有哪些新興趨勢與前景？

目錄

第 1 章執行摘要

第二章 市場概覽

  • 市場範圍與定義
  • 市場動態
    • 驅動程式
    • 阻礙因素
    • 機會
    • 課題
    • 主要趨勢
  • 藥品生命週期分析 馬獸藥市場：價值鏈
    • 原物料供應商名單
    • 製造商列表
    • 經銷商名單
    • 用途列表
    • 獲利能力分析
  • 波特五力分析
  • 地緣政治緊張局勢：市場影響
  • 宏觀經濟因素
    • 全球產業展望
    • 全球 GDP 成長前景
    • 全球母公司市場概覽
  • 預測因子：相關性和影響力
  • 監管與技術格局

第 3 章。
  • 主要亮點
    • 市場規模預測（基於數量）
    • 市場規模與年成長率
    • 絕對的獲利機會
  • 市場規模分析與預測（價值基礎（十億美元））
    • 過往市場規模分析（2019-2023 年）
    • 當前市場規模預測（2025-2032）
  • 全球馬獸藥市場展望（依藥物類別）
    • 簡介/主要發現
    • 按藥物類型劃分的歷史市場規模表現（價值（十億美元）和數量，2019 年至 2023 年）
    • 按藥物類型劃分的當前市場規模預測（價值（十億美元）和數量，2025 年至 2032 年）
      • 抗發炎劑
      • 抗感染藥物
      • 解毒劑
      • 其他
  • 依藥物進行市場吸引力分析
  • 按給藥途徑劃分的全球馬獸藥市場展望
    • 簡介/主要發現
    • 按給藥途徑劃分的歷史市場規模表現（價值（十億美元）和數量，2019 年至 2023 年）
    • 按給藥途徑劃分的當前市場規模預測（價值（十億美元）和數量，2025 年至 2032 年）
      • 口服
      • 腸外
      • 本地
  • 依給藥途徑進行市場吸引力分析
  • 全球馬獸藥市場展望（按服務）
    • 簡介/主要發現
    • 按服務劃分的歷史市場規模表現（價值（十億美元）和數量，2019 年至 2023 年）
    • 目前按服務劃分的市場規模預測（價值（十億美元）和數量，2025 年至 2032 年）
      • 診斷測試和影像
      • 身體健康監測
      • 手術
      • 疫苗接種
      • 其他
  • 依服務進行市場吸引力分析
  • 按通路劃分的全球馬獸藥市場展望
    • 簡介/主要發現
    • 按分銷管道劃分的歷史市場規模表現（價值（十億美元）和數量，2019 年至 2023 年）
    • 按分銷管道劃分的當前市場規模預測（價值（十億美元）和數量，2025 年至 2032 年）
      • 獸醫診所
      • 獸醫診所
      • 藥局和藥局
      • 電子商務
      • 其他
  • 依分銷管道進行市場吸引力分析

4. 全球馬獸藥市場按地區展望

  • 主要亮點
  • 按地區劃分的歷史市場規模分析（價值（十億美元）和數量，2019 年至 2023 年）
  • 按地區劃分的當前市場規模預測（價值（十億美元）和數量，2025 年至 2032 年）
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 按地區進行市場吸引力分析

第 5 章。

第 6 章。

第 7 章。

8. 南亞和大洋洲馬獸醫治療市場展望：歷史（2019-2023 年）和預測（2025-2032 年）

第 9 章。

第 10 章。

第 11 章 競爭格局

  • 市佔率分析（2023年）
  • 市場結構
    • 競爭加劇圖：依市場劃分
    • 競爭資訊中心
    • 生產能力（表觀值）
  • 公司簡介（詳情：概述、財務狀況、策略、最新發展）
    • Merck Animal Heath
    • Affymetrix
    • Elanco Animal Health
    • Zoetis (Pfizer Animal Health)
    • Equine Health UK

第 12 章附錄

  • 分析法
  • 分析前提條件
  • 縮寫和縮寫
簡介目錄
Product Code: PMRREP33965

Persistence Market Research has recently released a comprehensive report on the worldwide market for equine veterinary therapeutics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global equine veterinary therapeutics market from 2025 to 2032.

Key Insights:

  • Equine Veterinary Therapeutics Market Size (2025E): USD 1.4 Billion
  • Projected Market Value (2032F): USD 2.3 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.7%

Equine Veterinary Therapeutics Market - Report Scope:

Equine veterinary therapeutics are critical for the prevention, diagnosis, and treatment of health conditions affecting horses. The market includes pharmaceuticals, vaccines, and nutritional supplements tailored to address equine-specific needs. These therapeutics are extensively used by veterinarians, equine clinics, and horse owners for the management of infections, joint disorders, parasitic infestations, and other health issues. Market growth is driven by rising awareness of equine health, increasing investments in equestrian sports, and advancements in veterinary medicine. The market also benefits from the growing adoption of preventive care solutions, such as vaccines and nutritional supplements, to ensure the well-being of horses.

Market Growth Drivers:

The global equine veterinary therapeutics market is propelled by several key factors, including the increasing prevalence of equine diseases such as colic, laminitis, and equine influenza. Rising participation in equestrian sports and recreational activities has elevated the focus on horse health, leading to higher spending on veterinary care. Moreover, advancements in biotechnology have resulted in the development of targeted therapies, enhancing treatment efficacy and minimizing side effects. Another critical driver is the growing awareness among horse owners about the importance of preventive healthcare, which has boosted the demand for vaccines and nutritional supplements. The expanding network of equine clinics and the rising availability of advanced diagnostic tools further support market growth.

Market Restraints:

Despite promising growth prospects, the equine veterinary therapeutics market faces challenges related to high treatment costs, limited availability of specialized veterinarians, and regulatory hurdles. The cost of equine pharmaceuticals and vaccines can be prohibitive for small-scale horse owners, particularly in emerging economies with limited disposable income. Additionally, stringent regulations governing the approval and use of veterinary drugs create compliance burdens for manufacturers and delay product launches. The risk of adverse effects associated with certain therapies and the lack of adequate insurance coverage for equine healthcare further restrain market growth.

Market Opportunities:

The equine veterinary therapeutics market presents significant growth opportunities driven by technological innovations, increasing urbanization, and evolving equine care standards. The integration of digital health technologies, such as wearable monitoring devices for horses, enhances early disease detection and promotes preventive care. Furthermore, the development of novel biologics and gene-based therapies opens new avenues for the treatment of previously untreatable conditions. The rising popularity of equestrian tourism and the growing focus on companion animal health create additional opportunities for market players. Strategic investments in research and development, coupled with collaborations between pharmaceutical companies and equestrian organizations, are expected to drive market expansion.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the equine veterinary therapeutics market globally?
  • Which product segments are experiencing the highest demand, and why?
  • How are advancements in veterinary medicine influencing the competitive landscape of the equine therapeutics market?
  • Who are the key players in the equine veterinary therapeutics market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global equine veterinary therapeutics market?

Competitive Intelligence and Business Strategy:

Leading players in the global equine veterinary therapeutics market, including Zoetis Inc., Merck Animal Health, and Boehringer Ingelheim, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies are investing in R&D to develop advanced therapies, including long-acting injectable drugs, biologics, and targeted treatments for chronic conditions like arthritis and laminitis. Partnerships with equine healthcare providers, equestrian associations, and veterinary schools facilitate product adoption and market penetration.

Key Companies Profiled:

  • Zoetis Inc.
  • Merck Animal Health
  • Boehringer Ingelheim
  • Elanco Animal Health
  • Dechra Pharmaceuticals
  • Virbac
  • Ceva Sante Animale
  • Vetoquinol S.A.

Equine Veterinary Therapeutics Industry Segmentation

By Drugs:

  • Anti-Inflammatory
  • Anti-Infective
  • Parasiticides

By Route of Administration:

  • Oral
  • Parental
  • Topical

By Services:

  • Diagnostic Tests and Imaging
  • Physical Health Monitoring
  • Surgery
  • Vaccination

By Distribution Channel:

  • Veterinary Hospital
  • Veterinary Clinics
  • Pharmacies and drug stores
  • E-commerce

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Equine Veterinary Therapeutics Market Snapshot, 2025 - 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Drugs Lifecycle Analysis
  • 2.4. Equine Veterinary Therapeutics Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Bn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019 - 2023
    • 3.2.2. Current Market Size Forecast, 2025 - 2032
  • 3.3. Global Equine Veterinary Therapeutics Market Outlook: Drugs
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Drugs, 2019 - 2023
    • 3.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
      • 3.3.3.1. Anti- Inflammatory
      • 3.3.3.2. Anti - Infective
      • 3.3.3.3. Parasiticides
      • 3.3.3.4. Others
  • 3.4. Market Attractiveness Analysis: Drugs
  • 3.5. Global Equine Veterinary Therapeutics Market Outlook: Route of Administration
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Route of Administration, 2019 - 2023
    • 3.5.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
      • 3.5.3.1. Oral
      • 3.5.3.2. Parental
      • 3.5.3.3. Topical
  • 3.6. Market Attractiveness Analysis: Route of Administration
  • 3.7. Global Equine Veterinary Therapeutics Market Outlook: Service
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Service, 2019 - 2023
    • 3.7.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
      • 3.7.3.1. Diagnostic Tests and Imaging
      • 3.7.3.2. Physical Health Monitoring
      • 3.7.3.3. Surgery
      • 3.7.3.4. Vaccination
      • 3.7.3.5. Others
  • 3.8. Market Attractiveness Analysis: Service
  • 3.9. Global Equine Veterinary Therapeutics Market Outlook: Distribution Channel
    • 3.9.1. Introduction / Key Findings
    • 3.9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Distribution Channel, 2019 - 2023
    • 3.9.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
      • 3.9.3.1. Veterinary Hospital
      • 3.9.3.2. Veterinary Clinics
      • 3.9.3.3. Pharmacies and drug stores
      • 3.9.3.4. E-commerce
      • 3.9.3.5. Other
  • 3.10. Market Attractiveness Analysis: Distribution Channel

4. Global Equine Veterinary Therapeutics Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019 - 2023
  • 4.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Region, 2025 - 2032
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 5.3.1. By Country
    • 5.3.2. By Drugs
    • 5.3.3. By Route of Administration
    • 5.3.4. By Service
    • 5.3.5. By Distribution Channel
  • 5.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
    • 5.5.1. Anti- Inflammatory
    • 5.5.2. Anti - Infective
    • 5.5.3. Parasiticides
    • 5.5.4. Others
  • 5.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
    • 5.6.1. Oral
    • 5.6.2. Parental
    • 5.6.3. Topical
  • 5.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
    • 5.7.1. Diagnostic Tests and Imaging
    • 5.7.2. Physical Health Monitoring
    • 5.7.3. Surgery
    • 5.7.4. Vaccination
    • 5.7.5. Others
  • 5.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 5.8.1. Veterinary Hospital
    • 5.8.2. Veterinary Clinics
    • 5.8.3. Pharmacies and drug stores
    • 5.8.4. E-commerce
    • 5.8.5. Other
  • 5.9. Market Attractiveness Analysis

6. Europe Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 6.3.1. By Country
    • 6.3.2. By Drugs
    • 6.3.3. By Route of Administration
    • 6.3.4. By Service
    • 6.3.5. By Distribution Channel
  • 6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkiye
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
    • 6.5.1. Anti- Inflammatory
    • 6.5.2. Anti - Infective
    • 6.5.3. Parasiticides
    • 6.5.4. Others
  • 6.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
    • 6.6.1. Oral
    • 6.6.2. Parental
    • 6.6.3. Topical
  • 6.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
    • 6.7.1. Diagnostic Tests and Imaging
    • 6.7.2. Physical Health Monitoring
    • 6.7.3. Surgery
    • 6.7.4. Vaccination
    • 6.7.5. Others
  • 6.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 6.8.1. Veterinary Hospital
    • 6.8.2. Veterinary Clinics
    • 6.8.3. Pharmacies and drug stores
    • 6.8.4. E-commerce
    • 6.8.5. Other
  • 6.9. Market Attractiveness Analysis

7. East Asia Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 7.3.1. By Country
    • 7.3.2. By Drugs
    • 7.3.3. By Route of Administration
    • 7.3.4. By Service
    • 7.3.5. By Distribution Channel
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
    • 7.5.1. Anti- Inflammatory
    • 7.5.2. Anti - Infective
    • 7.5.3. Parasiticides
    • 7.5.4. Others
  • 7.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
    • 7.6.1. Oral
    • 7.6.2. Parental
    • 7.6.3. Topical
  • 7.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
    • 7.7.1. Diagnostic Tests and Imaging
    • 7.7.2. Physical Health Monitoring
    • 7.7.3. Surgery
    • 7.7.4. Vaccination
    • 7.7.5. Others
  • 7.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 7.8.1. Veterinary Hospital
    • 7.8.2. Veterinary Clinics
    • 7.8.3. Pharmacies and drug stores
    • 7.8.4. E-commerce
    • 7.8.5. Other
  • 7.9. Market Attractiveness Analysis

8. South Asia & Oceania Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 8.3.1. By Country
    • 8.3.2. By Drugs
    • 8.3.3. By Route of Administration
    • 8.3.4. By Service
    • 8.3.5. By Distribution Channel
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
    • 8.5.1. Anti- Inflammatory
    • 8.5.2. Anti - Infective
    • 8.5.3. Parasiticides
    • 8.5.4. Others
  • 8.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
    • 8.6.1. Oral
    • 8.6.2. Parental
    • 8.6.3. Topical
  • 8.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
    • 8.7.1. Diagnostic Tests and Imaging
    • 8.7.2. Physical Health Monitoring
    • 8.7.3. Surgery
    • 8.7.4. Vaccination
    • 8.7.5. Others
  • 8.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 8.8.1. Veterinary Hospital
    • 8.8.2. Veterinary Clinics
    • 8.8.3. Pharmacies and drug stores
    • 8.8.4. E-commerce
    • 8.8.5. Other
  • 8.9. Market Attractiveness Analysis

9. Latin America Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 9.3.1. By Country
    • 9.3.2. By Drugs
    • 9.3.3. By Route of Administration
    • 9.3.4. By Service
    • 9.3.5. By Distribution Channel
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
    • 9.5.1. Anti- Inflammatory
    • 9.5.2. Anti - Infective
    • 9.5.3. Parasiticides
    • 9.5.4. Others
  • 9.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
    • 9.6.1. Oral
    • 9.6.2. Parental
    • 9.6.3. Topical
  • 9.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
    • 9.7.1. Diagnostic Tests and Imaging
    • 9.7.2. Physical Health Monitoring
    • 9.7.3. Surgery
    • 9.7.4. Vaccination
    • 9.7.5. Others
  • 9.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 9.8.1. Veterinary Hospital
    • 9.8.2. Veterinary Clinics
    • 9.8.3. Pharmacies and drug stores
    • 9.8.4. E-commerce
    • 9.8.5. Other
  • 9.9. Market Attractiveness Analysis

10. Middle East & Africa Equine Veterinary Therapeutics Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 10.3.1. By Country
    • 10.3.2. By Drugs
    • 10.3.3. By Route of Administration
    • 10.3.4. By Service
    • 10.3.5. By Distribution Channel
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Drugs, 2025 - 2032
    • 10.5.1. Anti- Inflammatory
    • 10.5.2. Anti - Infective
    • 10.5.3. Parasiticides
    • 10.5.4. Others
  • 10.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Route of Administration, 2025 - 2032
    • 10.6.1. Oral
    • 10.6.2. Parental
    • 10.6.3. Topical
  • 10.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Service, 2025 - 2032
    • 10.7.1. Diagnostic Tests and Imaging
    • 10.7.2. Physical Health Monitoring
    • 10.7.3. Surgery
    • 10.7.4. Vaccination
    • 10.7.5. Others
  • 10.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 10.8.1. Veterinary Hospital
    • 10.8.2. Veterinary Clinics
    • 10.8.3. Pharmacies and drug stores
    • 10.8.4. E-commerce
    • 10.8.5. Other
  • 10.9. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Dashboard
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Merck Animal Heath
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Affymetrix
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Elanco Animal Health
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Zoetis (Pfizer Animal Health)
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Equine Health UK
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations